Skip to main content
SpringerLink
Log in

Penile Doppler Ultrasound Predicting Cardiovascular Disease in Men with Erectile Dysfunction

  • New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Cardiovascular disease is a major cause of morbidity and mortality in the USA. Traditional risk factors such as obesity, physical inactivity, and diet are used to screen for cardiovascular disease. However, these risk factors miss a significant population who are at risk for future cardiac events. Erectile dysfunction (ED) has many associated conditions in common with cardiovascular disease and has been shown to be an independent risk factor for cardiovascular. Measurements made on penile Doppler ultrasound (PDU), such as cavernosal artery peak systolic velocity (PSV), cavernosal artery intima-medial thickness, and the finding of cavernosal artery calcification, are indicators of generalized vascular disease. Thus, elements of PDU can identify men at higher risk for cardiovascular disease. This review outlines the proper technique for PDU and the literature supporting the use of PDU to predict cardiovascular disease in men with erectile dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kochanek KD et al. Deaths: final data for 2009. Nat Vital Stat Rep. 2011;60(3):1–116.

    Google Scholar 

  2. Clark CJ, et al. Predicted long-term cardiovascular risk among young adults in the national longitudinal study of adolescent health. Am J Public Health. 2014: p. e1-e8.

  3. Rastrelli G et al. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. J Sex Med. 2014;11(1):173–86. This study found that peak systolic velocity as measured by ultrasound can predict increased risk for major cardiac events.

    Article  PubMed  Google Scholar 

  4. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.

    CAS  PubMed  Google Scholar 

  5. Hayashi T et al. Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project. J Womens Health (Larchmt). 2010;19(6):1129–38.

    Article  Google Scholar 

  6. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–7.

    Article  PubMed  Google Scholar 

  7. Bal K et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology. 2007;69(2):356–60.

    Article  PubMed  Google Scholar 

  8. Heidler S et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007;177(2):651–4.

    Article  PubMed  Google Scholar 

  9. Reilly CM et al. Androgenic regulation of NO availability in rat penile erection. J Androl. 1997;18(2):110–5.

    CAS  PubMed  Google Scholar 

  10. Nehra A et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol. 1998;159(6):2229–36.

    Article  CAS  PubMed  Google Scholar 

  11. Beckman JA et al. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation. 2001;103(12):1618–23.

    Article  CAS  PubMed  Google Scholar 

  12. Nishikawa T et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–90.

    Article  CAS  PubMed  Google Scholar 

  13. Creager MA et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108(12):1527–32.

    Article  PubMed  Google Scholar 

  14. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Doubilet PM et al. The penis. Semin Ultrasound CT MR. 1991;12(2):157–75.

    CAS  PubMed  Google Scholar 

  16. Patel U, Lees WR. Penile sonography, in ultrasound of superficial structures. In Solibiati L, Rizzatto, G, editors. Churchill Livingstone; 1995. p. 229–242.

  17. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol. 2003;58(7):514–23.

    Article  CAS  PubMed  Google Scholar 

  18. Kim SH et al. Doppler sonography of deep cavernosal artery of the penis: variation of peak systolic velocity according to sampling location. J Ultrasound Med. 1994;13(8):591–4.

    CAS  PubMed  Google Scholar 

  19. Roy C et al. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound. 2000;28(6):290–4.

    Article  CAS  PubMed  Google Scholar 

  20. Mancini M et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000;23(4):199–204.

    Article  CAS  PubMed  Google Scholar 

  21. van Ahlen H et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151(5):1227–30.

    PubMed  Google Scholar 

  22. Patel U et al. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol. 1993;48(1):18–24.

    Article  CAS  PubMed  Google Scholar 

  23. Cormio L et al. Resistance index as a prognostic factor for prolonged erection after penile dynamic colour Doppler ultrasonography. Eur Urol. 1998;33(1):94–7.

    Article  CAS  PubMed  Google Scholar 

  24. Broderick GA, Lue TF. The penile blood flow study: Evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991.

    Google Scholar 

  25. Shabsigh R et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143(5):924–7.

    CAS  PubMed  Google Scholar 

  26. Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153(6):1149–53.

    Article  CAS  PubMed  Google Scholar 

  27. Lue TF et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155(3):777–81.

    Article  CAS  PubMed  Google Scholar 

  28. Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin N Am. 1988;15(1):65–76.

    CAS  Google Scholar 

  29. Pescatori ES et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151(5):1209–16.

    CAS  PubMed  Google Scholar 

  30. Benson CB, Aruny JE, Vickers Jr MA. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol. 1993;160(1):71–3.

    Article  CAS  PubMed  Google Scholar 

  31. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212–20.

    Article  PubMed  Google Scholar 

  32. Chung E et al. Penile Doppler sonographic and clinical characteristics in Peyronie’s disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. BJU Int. 2012;110(8):1201–5.

    Article  PubMed  Google Scholar 

  33. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol. 2010;30(2):182–5.

    Article  CAS  PubMed  Google Scholar 

  34. Caretta N et al. Erectile dysfunction, penile atherosclerosis, and coronary artery vasculopathy in heart transplant recipients. J Sex Med. 2013;10(9):2295–302.

    Article  CAS  PubMed  Google Scholar 

  35. Caretta N et al. Cavernous artery intima-media thickness: a new parameter in the diagnosis of vascular erectile dysfunction. J Sex Med. 2009;6(4):1117–26.

    Article  PubMed  Google Scholar 

  36. Mulhall J, Teloken P, Barnas J. Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med. 2009;6(3):820–5.

    Article  PubMed  Google Scholar 

  37. Corona G et al. Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med. 2008;5(11):2623–34.

    Article  PubMed  Google Scholar 

  38. Rastrelli G et al. Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events. J Sex Med. 2011;8(12):3433–45. This study found that the degree of response to intracaveronsal injection of vasodilatory agents corresponds with risk of cardiac events.

    Article  PubMed  Google Scholar 

  39. Billups KL et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20(3):236–42.

    Article  CAS  PubMed  Google Scholar 

  40. Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30(4):328–38.

    Article  CAS  PubMed  Google Scholar 

  41. O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract. 2001;55(3):219–20.

    PubMed  Google Scholar 

  42. Corona G et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 2010;7(5):1918–27.

    Article  PubMed  Google Scholar 

  43. Shin D, Pregenzer Jr G, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19(1):5–11.

    Article  PubMed  Google Scholar 

  44. Zambon JP et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case–control study. Sao Paulo Med J. 2010;128(3):137–40.

    Article  PubMed  Google Scholar 

  45. Mottillo S et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

    Article  PubMed  Google Scholar 

  46. Bohm M et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 2010;121(12):1439–46.

    Article  PubMed  Google Scholar 

  47. Batty GD et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2011;56(23):1908–13.

  48. Tomada N, et al. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? the role of body fat mass assessment. J Sex Med.

  49. Miner MM, Erectile dysfunction: a harbinger or consequence: does its detection lead to a “window of curability?”. J Androl. This meta-analysis shows that erectile dysfunction is independently associated with cardiovascular disease and treatment of reversible risk factors can prevent future cardiac events.

  50. Inman BA et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–13.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137(5):829–36.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Nikhil Gupta, Dr. Amin Herati, and Dr. Bruce R. Gilbert each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. The Arthur Smith Institute for Urology, Hofstra North Shore LIJ School of Medicine, 450 Lakeville Road, Suite M41, New Hyde Park, NY, 11040, USA

    Nikhil Gupta, Amin Herati & Bruce R. Gilbert

Authors
  1. Nikhil Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amin Herati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruce R. Gilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce R. Gilbert.

Additional information

This article is part of the Topical Collection on New Imaging Techniques

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, N., Herati, A. & Gilbert, B.R. Penile Doppler Ultrasound Predicting Cardiovascular Disease in Men with Erectile Dysfunction. Curr Urol Rep 16, 16 (2015). https://doi.org/10.1007/s11934-015-0482-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-015-0482-1

Keywords

Search

Navigation